AMD OPTI, LLC, is a US-based company that is specialized in regenerative medicine applications and cell-based therapies. AMD OPTI develops, funds, and owns patents for various medical procedures related to treatment of chronic human conditions.
Previously, we have funded and managed projects that utilize our patented technology in treatment of specific human diseases such as Age-related Macular Degeneration (AMD) in different parts of the world.
Our collaborators and partners are scientists, researchers and business entities from different institutions and private companies in various countries.
